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Este trabalho revela uma estratégia biotecnológica incomum mas valiosa e relacionada com o uso
de um mesmo polímero (benzidrilamino-resina, BHAR) para fins de síntese e purificação por troca
aniônica de peptídeos. Inicialmente, o octapeptídeo DRVYIHPF-NH2 foi sintetizado em BHAR
com 1% e 3% de intercruzamento e contendo 2,5 mmol g-1 de grupos amônio. Devido certamente a
uma menor rigidez da sua estrutura polimérica, um maior rendimento na síntese (cerca de 80%) foi
obtido com a primeira resina. A seguir, os peptídeos DEVYEHPF-NH2 e DEVYEDPF-NH2
carregados negativamente (-1 e -3 em pH neutro, respectivamente), ambos sintetizados em 1%
BHAR, foram submetidos a um teste de separação cromatográfica no mesmo tipo de resina (1% e
3%). Concordante com resultados da síntese de peptídeos e de valores de inchamento dos grãos das
resinas, obtidos por microscopia, uma melhor separação entre ambos os peptídeos ocorreu com o
lote de 1% BHAR. Estes achados demonstraram que a BHAR, aplicada até o momento somente para
a síntese peptídica, se contiver elevado teor de grupos amônio positivos, pode ser utilizada
alternativamente como suporte sólido para purificação cromatográfica deste tipo de molécula biológica.
This work reveals an uncommon but valuable biotechnological approach regarding the use of a
same polymer (benzhydrylamine-resin, BHAR) for synthesis and anion exchange purification of
peptides. Initially, the octapeptide DRVYIHPF-NH2 was synthesized in 1% and 3% cross-linked
BHAR, attaching 2.5 mmol g-1 ammonium groups. Due certainly to its less rigid polymeric backbone,
higher synthesis yield (about 80%) was achieved with the former resin. Next, the negatively charged
peptides DEVYEHPF-NH2 and DEVYEDPF-NH2 (-1 and -3 in neutral pH, respectively), both
synthesized in 1% BHAR were submitted to chromatographic separation test in this same type of
resin (1% and 3%). Following comparative results of peptide synthesis and swelling data of resin
beads obtained by microscopy, an improved separation of both peptides occurred with 1% BHAR
batch. These findings demonstrated that BHAR applied so far for peptide synthesis, when containing
high amount of positively charged ammonium groups, can be also used alternatively as a solid
support for chromatographic purification of this type of biological molecule.
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Introduction
The inception of solid phase peptide synthesis (SPPS)1
almost four decades ago2 represented a landmark in the
use of cross-linked beaded polymers, which were, until
that time, restricted to stationary phases in column
chromatography. Since then, various studies have been
conducted in order to develop more varied applications
for such polymeric materials. In addition to the peptide
synthesis method itself, the concept of performing
chemical reactions on an insoluble polymeric structure
has, for instance, been successfully extended to
oligonucleotides3 and polysaccharides.4 In recent years, a
process denoted solid phase organic synthesis,5,6 which
employs a combinatorial chemistry approach, has proven
fruitful in the generation of peptide libraries7,8 and new
therapeutic drugs.9
Since that time, a large number of different resins have
been developed.10,11 One of the first used for application in
SPPS,12-14 was the benzhydrylamine-resin (BHAR), a
phenylmethylamine group-bearing copoly (styrene-
divinylbenzene)-type polymer for the synthesis of
α-carboxamide peptides.15 Due to the dominant
hydrophobic character of the styrene component of the
resin, improved solvation of its matrix, containing usually
low 0.2-0.5 mmol g-1 amine groups (degree of substitution)
for peptide chain growth, occurs preferably in apolar
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organic solvents. However, increasing the degree of
substitution may drastically alter this BHAR solvation
profile. We have previously demonstrated that very highly
ammonium substituted BHAR batches (>1.5-2.0 mmol g-1)
actually display improved swelling in polar solvents,
including water.16 These findings prompted us to initiate
the evaluation of its use as ion exchange supports for
purification of negatively charged disaccharides17 and
gangliosides18 in aqueous solution. Some physicochemical
characteristics of this type of cationic resin have also been
described.19
As a continuation of these studies, the aim of the present
report was to demonstrate a different biotechnological
application, i.e., the possibility of synthesizing and
purifying (by ion exchange procedure) negatively charged
peptides with the same polymer (highly substituted BHAR).
Furthermore, in order to evaluate the effect of the degree
of divinylbenzene cross-linking of the resin, the synthesis
and purification of model negatively charged peptides
were both carried out in highly substituted (2.5 mmol g-1)
BHAR containing 1% and 3% cross-linking degrees. As a
preliminary step, BHAR batches with protonated (for anion-
exchange chromatography) and deprotonated (for coupling
reaction during peptide synthesis) amine functions were
submitted to solvation studies through microscopy for
measurement of the diameters of the dry and swollen resin
beads.16,20 This approach correlates the swelling properties
of each resin with a novel solvent polarity scale previously
proposed by this laboratory21,22 in order to facilitate the
choice of the most appropriate solvent system for
optimized solvation of each solid support. In fact, the
present study represents an inverted strategy recently
proposed, in which classical anion-exchange resins such
as DEAE-MacroPrep® (BioRad Laboratories, Hercules, CA,
USA) and DEAE-Sephadex A50® (Amersham Biosciences,
Piscataway, NJ, USA) were used for peptide synthesis and
for further dual-affinity anion-exchange purification of
antibody molecules correlated with malaria transmission.23
Experimental
All amino acid derivatives were purchased from Bachem,
Torrance, CA, USA. Solvents and reagents were acquired
from Aldrich-Sigma and Advanced ChemTech Inc. The
DEAE-MacroPrep® resin and copoly (styrene-1% and 3%
divinylbenzene) resins (BioBeads SX-1® and SX-3®) were
bought from BioRad Laboratories, Hercules, CA, USA.
Peptide synthesis
The peptides were synthesized manually accordingly
to the standard Nα-Boc/Bzl protecting group strategy.12,13
The following Boc-amino acid derivatives were used:
cyclohexyl for Asp and Glu; tosyl for Arg and His and
2-Br-carbobenzoxy for Tyr. After the coupling of the
C-terminal amino acid to the resin, the successive α-amino
group deprotection and neutralization steps were
performed in 30% TFA/DCM (30 min) and 10% TEA/DCM
(10 min), respectively. In most cases, the amino acids were
coupled at 3-fold excess using DIC/HOBt in DCM/DMF
(1:1, v/v) and, if necessary, HBTU/HOBt/DIEA in 20%
DMSO/NMP for recoupling steps. After a two-hour
coupling time, the ninhydrin test was performed to estimate
the completeness of the reaction. Anhydrous HF was used
for cleavage of the peptide from the resin. To enhance the
yield of peptide removal from the resin when the
hydrophobic amino acid residues are located at the
C-terminal position attached to BHAR, a 4 h reaction at
0 °C was used.24 The peptides were extracted into 5%
aqueous HOAc and lyophilized.
Analytical HPLC
Analysis was performed in a Waters system consisting
of two 510 HPLC pumps, an automated gradient controller,
a Rheodyne manual injector, a 486 detector and a 746
data module. Unless otherwise stated, peptides were
analyzed in a C18 Vydac column (4.6 x 150 mm, 300 Å
pore size, 5 mm particle size) with the solvent systems A:
H2O containing 0.1% TFA; and B: 90% MeCN in H2O
containing 0.08% TFA. A linear gradient of 10-90% B in
54 min was applied at a flow rate of 2.0 mL min-1 and with
detection at 210 nm.
Preparative HPLC
Purification of peptides was carried out as follows:
solvent A: H2O containing 0.1% TFA; solvent B: 90%
MeCN in H2O containing 0.08% TFA. Retention time-
dependent linear gradients were determined through
analytical HPLC of the peptide with the same solvent
systems. The flow rate was 6.0 mL min-1 and peak detection
was at 210 nm.
Synthesis of highly substituted benzhydrylamine-resins
Synthesis of the highly substituted BHAR batches was
controlled through specific forcing of the benzoylation step,
as has been previously described.16 The proportion of
acylating agents, benzoyl chloride and aluminum chloride
for the 2.5 mmol g-1 BHAR batches (1% and 3% cross-
linkage) was, typically, 4 mmol g-1 of styrene-1%
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divinylbenzene copolymer in a concentration of 0.8 mol L-1
at 35°C for 15 h. For both batches, the reductive amination
step (Leuckart reaction) was carried out with an excessive
amount of reactant (60 mmol per gram of benzoylated
copolymer) for 30 h at 170°C. In order to generate the free
ammonium group in the resin, hydrolysis of the formyl
group-bearing copolymer was performed by refluxing with
a mixture of 12 N HCl:EtOH (1:1, v/v) at 90°C for 5 h.
Swelling measurement of resin beads
Prior to their use in chromatography and microscopic
measurement of bead sizes, the amino protonated (Cl- form)
or deprotonated (treated with 10% TEA/DCM) BHAR
batches were dried in vacuo using an Abderhalden-type
apparatus with MeOH reflux. They were then exhaustively
sized, a process which entailed suspending them in DCM
and EtOH and sifting them through pore metal sieves to
lower the standard deviations of resin diameters to
approximately 4-5%. After being allowed to equilibrate
overnight, 150 to 200 dry and swollen beads of each resin
were spread onto a microscope slide and measured directly
at low magnification in an Olympus, model SZ 11
microscope linked to the software program Image Plus,
version 3.0.01.00. Since the sizes in a sample of beads are
log-normally (rather than normally) distributed, the central
value and the distribution of the particle diameters were
estimated using more accurate geometric mean values and
geometric standard deviations.25 The average amount of
solvent (in percentage) absorbed by the resin beads was
calculated by the equation:
[(swollen volume – dry volume)/swollen volume] x 100
where bead volumes were calculated from their diameters.
Mass Spectrometry
The LC/ESI-MS experiments were performed on a
system consisting of a Waters Alliance model 2690
separations module and model 996 photodiode array
detector (Waters, Eschborn, Germany) controlled with a
Compaq AP200 workstation coupled to a Micromass model
ZMD mass detector (Micromass, Altrincham, Cheshire,
UK). The samples were automatically injected on a Waters
narrow bore Nova-Pak column C18 (2.1 x 150 mm, 60 Å
pore size, 3.5 µm particle size). The elution was carried out
with solvents A (0.1% TFA/H2O) and B (60% acetonitrile/
0.1% TFA/H2O) at a flow rate of 0.4 mL min-1 using a linear
gradient from 5% to 95% B in 30 min. The condition used
for mass spectrometry measurements was a positive ESI.
Amino acid analyzer
Peptide composition was controlled by amino acid
analysis (AAA) which was performed on Biochrom 20 Plus
amino acid analyzer (Pharmacia LKB Biochrom Ltd.,
Cambridge, England) equipped with an analytical cation-
exchange column. The peptides were hydrolyzed with HCl
6 mol L-1 in sealed tubes under nitrogen atmosphere at
110°C for 72 h. The samples were concentrated in high
vacuum, suspended in 0.2 mol L-1 sodium citrate buffer,
adjusted to pH 2.2 and automatically injected into the
analyzer.
Anion-exchanger chromatography
The 1% and 3% BHAR batches were pre-treated with
20% EtOH in water and washed thoroughly with the initial
buffer before being packed into the column. The linear
pH-gradients used for elution were from 0.02 mol L-1
NH4Ac, pH 5 to 10% HOAc, pH 2.3, or from 0 to 2 mol L-1
NaCl linear salt-gradient in NH4Ac, pH 5, using a GM-1
Mixer (Amersham Pharmarcia Biotech) and a Foxy 200
collector (Isco, Lincoln, NE, USA). The amount of
positively charged groups per column was fixed at 4 mmol,
including (for comparison) the commercial DEAE-
MacroPrep® resin.
Results and Discussion
Swelling degree of BHAR
To identify the solvent systems which swell the 1%
and 3% BHAR to a greater degree, the two 2.5 mmol g-1
substituted batches were initially studied with their amine
function in protonated (chloride) and deprotonated forms.
Table 1 displays the 25 solvent systems (single and mixed)
used for swelling studies of dry and swollen beads under
microscopy. These solvent systems encompass a broad
section of the polarity scale represented by the (AN+DN)
constant.21,22 The AN and DN terms represent Gutmann’s
electron acceptor and electron donor numbers,26
respectively. Due to the coexistence of two opposite
conceptual physicochemical terms, this novel polarity scale
was recently designated amphoteric.27 The volume of
solvated bead (in percentage) occupied by each solvent
system was selected as swelling parameter to monitor
solvation capacity of resin batches in ionized and non-
ionized forms.
By examining the swelling values shown in Table 1, it
can be seen that the swelling percentages of the resins
ranged from a minimum of approximately 30%
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(deprotonated 1% BHAR in EtOH) to a maximum of 91%
(protonated 1% BHAR in DMSO). The equation below
was used to determine the (AN+DN) parameter values of
mixed solvents according to AN and DN numbers.26
X1+2 = φ1 x1 + φ2 x2
where x1 and x2 are the solvent parameters for the two
components of the mixture, and φ1 and φ2 are the
corresponding volume fractions. This equation has
previously been applied to other solvent properties.28,29
Figure 1 compares the plots of swelling degree versus
(AN+DN) solvent polarity values for 1% and 3% BHAR
when amine groups are attached in protonated (panels A
and C) and deprotonated (B and D) forms. A clear
differentiation in swelling profile could be observed
between these resins with these two forms of the amine
function. Regardless of the cross-linking percentage, the
amino protonated resins displayed enhanced bead
swelling in more polar solvents, characterized by greater
(AN+DN) values. Optimized swelling occurred with
solvent systems characterized by high polarity, defined as
approximately 50 or greater on the (AN+DN) polarity
scale.22 In contrast to their protonated counterparts, the
amine deprotonated BHAR batches depicted better
solvation in more apolar solvents, with the region of
maximum solvation shifted to solvent systems with
(AN+DN) values of approximately 20.
Table 1. Swelling of 1 and 3% BHAR with amine groups in
deprotonated and protonated forms
 BHAR (% cross-linking)a
Polarity 1 3 1 3
Nº Solvent (AN+DN) Deprotonated Protonatedb
1 Toluene 3.4 78 67 46 46
2 DCM 21.4 81 82 59 5 6
3 Chloroform 27.1 80 80 65 6 3
4 NMP 40.6 79 73 82 6 6
5 DMF 42.6 79 68 88 6 8
6 DMSO 49.1 56 69 91 7 6
7 TFE 53.5 67 64 84 6 7
8 EtOH 69.1 30 36 88 6 4
9 MeOH 71.3 28 37 86 6 0
10 Formamide 63.8 31 47 82 6 4
11 50% TFE/TOL 28.5 81 82 80 6 7
12 20% TFE/DCM 27.5 85 81 73 7 2
13 50% TFE/DCM 37.5 69 74 79 7 3
14 80% TFE/DCM 47.4 66 59 77 6 3
15 20% DMSO/NMP 42.3 71 65 83 7 9
16 50% DMSO/THF 38.6 74 75 88 7 6
17 65% NMP/THF 36.1 78 80 82 7 2
18 50% DCM/DMF 32.0 70 72 74 6 5
19 50% DCM/DMSO 35.3 73 68 86 7 5
20 50% MeOH/DMSO 60.2 58 59 89 7 0
21 50% TFE/DMF 48.1 64 69 83 6 9
22 50% TFE/DMSO 51.3 57 54 91 7 9
23 10% TEA/DCM 25.1 85 85 nd nd
24 10% TEA/DMF 44.5 80 78 nd n d
25 10% TEA/DMSO 50.4 73 73 nd n d
a(swollen volume – dry volume) / swollen volume x 100; using the
following diameters of dry beads: BHAR: 1% (43 µm), 3% (45 µm);
nd = not determined; b (Cl- form).
Figure 1. Correlation between swelling of different cross-linked BHAR as a function of the (AN+DN) polarity parameter. A (1%) and C (3%),
amine groups in protonated form. B (1%) and D (3%), amine groups in deprotonated form.
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It is of note, and antithetical to the results obtained
with the amine deprotonated resins, that the protonated
1% BHAR showed a slightly greater degree of swelling
(approximately 90%) in the maximum solvation region in
comparison to the 80% swelling observed in its 3%
counterpart (Figure 1). This finding is likely due to the
fact that, when the cross-linking percentage is higher, the
resin matrix structure is more rigid and therefore hinders
expansion of the polymer backbone.
Moreover, all four contour plots of resin swelling clearly
show the maximum solvation region of each resin (Figure
1), thus reconfirming the accuracy of the (AN+DN) term in
reflecting polarity of the medium. The results of previous
studies of more traditional polarity scales such as
Hildebrand’s δ term,30 Dimroth-Reichardt´s Et3031 or even
the dielectric constant support our findings. In summary,
the swelling displayed by the BHAR batches confirmed
our hypothesis that batches containing high amounts of
protonated amine forms, due to the positively charged
groups attached to their structure, swelled to a greater
degree in more polar solvents. As evidence of this, the 1%
and 3% BHAR protonated batches displayed good
swelling capacity (70% and 50%, respectively) when
measured in the 0.02 mol L-1 aqueous ammonium acetate
buffer (pH 5.0) commonly used for ion exchange
chromatography at the initial equilibrium and solute
loading steps.
Comparative peptide synthesis
Following the solvation studies, both 1% and 3%
BHAR batches were compared as to their capacity for
peptide synthesis applications. The vasoactive angiotensin
II (DRVYIHPF, AII) was selected as the model peptide for
comparative synthesis yielding its Ca-amide analogue. The
synthesis efficiency was clearly superior when the 1%
BHAR batch was used. No difficulties in assembling the
entire peptide chain were observed, and there was no need
for any recoupling process during the progressive
attachment of amino acid residues of the sequence.
Conversely, when the 3% BHAR was used, many more
difficulties occurred, including multiple recoupling
reactions throughout the synthesis.
The composite Figure 2 displays the analytical HPLC
profiles of crude peptides synthesized with both BHAR
batches. The AII synthesis yield was based upon the area
of the AII peak in the HPLC chromatogram and indicated
values of approximately 80% and 35%, respectively, when
1% and 3% BHAR batches were used for the synthesis,
respectively. These results are again likely due to the more
Figure 2. Analytical HPLC profiles of crude AII–NH2 synthesized in (A) 1% and (B) 3% BHARs. Absorbance, detection at 210 nm.
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rigid and sterically hindered polymer backbone of the
latter BHAR batch, which seems to severely impede
diffusion of reactants and side products during the peptide
synthesis.
Use of BHAR as an anion-exchange resin
To compare the anion-exchange capacity of 1% and
3% protonated BHAR batches, the negatively charged
peptides DEVYEHPF-NH2 (P2) and DEVYEDPF-NH2 (P3)
– with net charges of about –1 and –3 at pH 5 – were
previously synthesized in the 1% BHAR. As expected, the
synthesis yield was approximately 80-85%, yielding 71
and 79 mg of the desired peptides, respectively (on a 0.1
mmol synthesis scale). The HPLC profiles of these two
crude peptides resembled closely those shown in Figure 2
(AII-NH2). To complete the set of peptides necessary for
the comparative anion-exchange chromatography with
BHAR, the model AII-NH2 (P1) – previously synthesized
in the 1% versus 3% BHAR comparative study – was used
as a control for the void volume determination of columns
due to the positive charge of this sequence at pH 5 (+2).
These three crude peptide sequences were purified until
homogeneity in conventional HPLC purification prior to
use for separation test with 1% and 3% BHAR batches.
Columns for chromatographic experiments and
containing 4 mmol of ammonium groups of 1% BHAR,
3% BHAR and also the commercial weak anion-exchange
DEAE-MacroPrep® resins were previously equilibrated in
0.02 mol L-1 ammonium acetate buffer, pH 5. Through a
swelling versus pH of the medium approach, we have
previously demonstrated that, at this and lower pH levels,
the amine groups of BHAR are totally protonated, since
an average pKa value of approximately 7 was determined
for this basic function.32 A pH-gradient ranging from pH 5
to 2.3 (10% HOAc) was applied. Figure 3 displays
comparative chromatograms showing the observed anion-
exchange of peptides P1, P2 and P3 in 1% BHAR, 3%
BHAR and DEAE-MacroPrep® resin. More succeeded
separation of the negatively charged P2 and P3 peptides
occurred mainly with 1% BHAR, indicating that for the
3% BHAR batch, variation in the chromatographic
Figure 3. Anion exchange chromatography of P1: DRVYIHPF-NH2 (+2); P2: DEVYEHPF-NH2 (-1) and P3: DEVYEDPF-NH2 (-3) on: (A) 1%
BHAR; (B) 3% BHAR; and (C) DEAE-MacroPrep®. Conditions: 4.0 mmol of ammonium groups per column and linear pH-gradient from 0.02
mol L-1 ammonium acetate, pH 5 to 10% HOAc, pH 2.3 (200 mL each). Absorbance, detection at 254 nm.
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Figure 4. Anion exchange chromatography of P1: DRVYIHPF-NH2 (+2); P2: DEVYEHPF-NH2 (-1) and P3: DEVYEDPF-NH2 (-3) on: (A) 1%
BHAR; (B) 3% BHAR; and (C) DEAE-MacroPrep®. Conditions: 4.0 mmol of ammonium groups per column and linear pH-gradient from 0 to
2 mol L-1 NaCl gradient in 0.02 mol L-1 ammonium acetate, pH 5 (200 mL each). Absorbance, detection at 254 nm.
condition should be necessary for achievement of
improved resolution and elution of solutes. The worse
performance of the 3% BHAR in terms of anion-exchange
capacity seems to be due to its more compact and sterically
hindered matrix. Otherwise, the commercial DEAE-
MacroPrep® resin also succeeded in the separation of
components, but the elution of the two negative peptides
was more rapid than it was with the 1% BHAR.
Finally, Figure 4 shows the same comparative
experiments, but, in this case, the salt gradient (0 to 2 mol
L-1 NaCl gradient) was applied. Poorer fractionation results
were obtained with both BHAR batches, and retention of
the two negative peptides was stronger than that observed
during the pH gradient. The 1% BHAR only partially eluted
the injected peptides, whereas the remaining quantity of
solutes could only be removed with strong 20% HOAc
aqueous solution. Again, the worst result was observed
with 3% BHAR, which completely retained both negatively
charged peptides in the column and eluted with the 20%
HOAc aqueous solution wash. In this salt-gradient protocol,
the best results were obtained with the commercial DEAE-
MacroPrep® resin. The poorer chromatographic behavior
of BHAR when the salt gradient was applied might be due
to the well-known fact that its beads shrink in aqueous
solution of high ionic strength.19
In conclusion, similar to the results obtained when 1%
and 3% BHAR were used for peptide synthesis, the best
results in terms of application for anion-exchange
chromatography were observed with the former batch.
Collectively, these findings are in close accordance with
the improved solvation in organic (for peptide synthesis)
or aqueous (for column chromatography) media of the 1%
resin over the 3% resin. Most relevantly, the results herein
obtained thus proved the feasibility of using BHAR for
synthesis and purification of the same type of compound
(negatively charged peptides). However one must stress
that these two types of technological applications are much
more effective when low cross-linked and highly amine
substituted BHAR batches are to be used.
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